Clinical Utility of Biomarkers in Premature Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|16|2521-2533

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.16, 2012-06, pp. : 2521-2533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor Biomarkers: Clinical Utility, Promises and Problems

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 1, 2014-04 ,pp. : 51-55

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation

By Ong Frank S   Deignan Joshua L   Kuo Jane Z   Bernstein Kenneth E   Rotter Jerome I   Grody Wayne W   Das Kingshuk  

Pharmacogenomics, Vol. 13, Iss. 4, 2012-03 ,pp. : 465-475

Future Medicine

Access to resources Recommend Favorite

An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice

By Leeming D.   Alexandersen P.   Karsdal M.   Qvist P.   Schaller S.   Tankó L.  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 10, 2006-10 ,pp. : 781-792

Springer Publishing Company

Access to resources Recommend Favorite

Inflammatory Biomarkers Predicting Events in Atherosclerosis

By  

Current Medicinal Chemistry, Vol. 17, Iss. 16, 2010-06 ,pp. : 1690-1707

Bentham Science Publishers

Access to resources Recommend Favorite

Infection-Associated Biomarkers of Inflammation in Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 13, 2015-04 ,pp. : 1776-1782

Bentham Science Publishers

Access to resources Recommend Favorite